Cui Junyi, Jia Handi
Department of Neurology, The People's Hospital of Suzhou New District, Suzhou, China.
Department of Chinese Medicine, The People's Hospital of Suzhou New District, Suzhou, China.
Evid Based Complement Alternat Med. 2022 Aug 26;2022:5990203. doi: 10.1155/2022/5990203. eCollection 2022.
The aim of this study is to explore the therapeutic effect of Xingnao kaiqiao acupuncture combined with butylphthalide sodium chloride injection on acute cerebral infarction and its effect on the levels of serum malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH).
120 patients with acute cerebral infarction who were treated in our hospital from March 2020 to March 2022 and met the inclusion and exclusion criteria were divided into two groups. The control group was treated with sodium butylphthalide chloride injection, and the study group was treated with Xingnao kaiqiao acupuncture combined with sodium butylphthalide chloride injection.
After treatment, the levels of neurotransmitters, the TTP and RI and MDA in both groups decreased, and the Qmean, CBV values, and the levels of SOD and GSH increased, and the changes of index in the study group were more significant than those in the control group ( < 0.05). After treatment, the NIHSS score and syndrome score of the two groups decreased, the MMSE score increased, the NIHSS score and syndrome score of the study group decreased more significantly than that of the control group, and MMSE score increased more significantly than that of the control group ( < 0.05). In terms of clinical efficacy, the total effective rate of the study group was higher than that of the control group ( < 0.05).
Xingnao kaiqiao acupuncture combined with butylphthalide sodium chloride injection is effective in patients with acute cerebral infarction. It can improve the level of neurotransmitters and cerebral blood flow perfusion and inhibit the abnormal expression of MDA, SOD, and GSH.
本研究旨在探讨醒脑开窍针刺联合丁苯酞氯化钠注射液治疗急性脑梗死的疗效及其对血清丙二醛(MDA)、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH)水平的影响。
选取2020年3月至2022年3月在我院治疗的120例符合纳入和排除标准的急性脑梗死患者,分为两组。对照组采用丁苯酞氯化钠注射液治疗,研究组采用醒脑开窍针刺联合丁苯酞氯化钠注射液治疗。
治疗后,两组神经递质水平、TTP、RI及MDA均降低,Qmean、CBV值及SOD、GSH水平升高,且研究组指标变化较对照组更显著(P<0.05)。治疗后,两组NIHSS评分及证候评分降低,MMSE评分升高,研究组NIHSS评分及证候评分降低幅度较对照组更显著,MMSE评分升高幅度较对照组更显著(P<0.05)。在临床疗效方面,研究组总有效率高于对照组(P<0.05)。
醒脑开窍针刺联合丁苯酞氯化钠注射液治疗急性脑梗死患者疗效显著。可提高神经递质水平及脑血流灌注,抑制MDA、SOD、GSH的异常表达。